WAM
Weiss Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,800
| Closed | -$5.78M | – | 582 |
|
|
2024
Q2 | $5.78M | Sell |
23,800
-876
| -4% | -$213K | 0.22% | 91 |
|
|
2024
Q1 | $3.69M | Buy |
24,676
+23,484
| +1,970% | +$3.51M | 0.13% | 119 |
|
|
2023
Q4 | $228K | Buy |
+1,192
| New | +$228K | 0.01% | 264 |
|
|
2022
Q4 | – | Sell |
-24,450
| Closed | -$4.89M | – | 522 |
|
|
2022
Q3 | $4.89M | Buy |
+24,450
| New | +$4.89M | 0.12% | 230 |
|
|
2018
Q4 | – | Sell |
-2,460
| Closed | -$215K | – | 446 |
|
|
2018
Q3 | $215K | Hold |
2,460
| – | – | 0.02% | 137 |
|
|
2018
Q2 | $242K | Hold |
2,460
| – | – | 0.02% | 124 |
|
|
2018
Q1 | $293K | Hold |
2,460
| – | – | 0.02% | 133 |
|
|
2017
Q4 | $313K | Buy |
+2,460
| New | +$313K | 0.03% | 150 |
|